Displaying 109 - 119 of 119
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Immune-Mediated and Cholestatic Diseases
3

Albireo: New Developments in the Management of Progressive Familial Intrahepatic Cholestasis (PFIC) - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
3

Albireo: New Developments in the Management of Progressive Familial Intrahepatic Cholestasis (PFIC) - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
3

Albireo: New Developments in the Management of Progressive Familial Intrahepatic Cholestasis (PFIC) - ILC 2021

View
Displaying 109 - 119 of 119